Nyrada Inc. confirmed the appointment of Cameron Jones as Chief Financial Officer. Cameron replaces Shawn van Boheemen who oversaw the Company's IPO and ASX-listing process, operating under a shared services agreement with major Nyrada shareholder Noxopharm. Cameron is the Managing Director of Bio101 and acts as CFO and Company Secretary for several ASX listed and venture capital life science companies.